25 Sept 2026, 17:20
Meetings & Governance—
IXCINVEX THERAPEUTICS LTD
Announcement history available from 1 August 2025
Fromto
31 Aug 2026, 19:18
Company Administration—
31 Aug 2026, 19:17
Financial ResultsMS
23 July 2026, 18:14
Quarterly ReportsMS
24 Apr 2026, 12:13
Quarterly ReportsMS
24 Apr 2026, 08:11
Company Update—
23 Mar 2026, 12:27
Company Administration—
17 Feb 2026, 18:40
Meetings & Governance—
12 Feb 2026, 13:34
Financial ResultsMS
22 Jan 2026, 16:16
Quarterly ReportsMS
16 Jan 2026, 12:38
Meetings & Governance—
20 Nov 2025, 20:23
Meetings & Governance—
10 Nov 2025, 13:02
Director Interests—
10 Nov 2025, 09:38
ReinstatementMS
10 Nov 2025, 09:37
Company AdministrationMS
7 Nov 2025, 15:44
Director Interests—
7 Nov 2025, 15:22
Director Interests—
7 Nov 2025, 15:22
Meetings & Governance—
7 Nov 2025, 14:41
Trading Halt / SuspensionMS
7 Nov 2025, 14:20
Trading Halt / SuspensionMS
3 Nov 2025, 14:11
Company Update—
24 Oct 2025, 15:07
Meetings & Governance—
17 Oct 2025, 16:02
Substantial Holders—
8 Oct 2025, 15:34
Meetings & Governance—
3 Oct 2025, 09:16
Quarterly ReportsMS
30 Sept 2025, 09:55
ReinstatementMS
30 Sept 2025, 09:55
ASX QueryMS
30 Sept 2025, 09:55
Company UpdateMS
29 Sept 2025, 12:09
Meetings & Governance—
29 Sept 2025, 09:27
Other—
25 Sept 2025, 09:40
Trading Halt / SuspensionMS
23 Sept 2025, 11:35
Trading Halt / SuspensionMS
23 Sept 2025, 10:38
Trading Halt / SuspensionMS
18 Sept 2025, 10:42
Company Administration—
11 Aug 2025, 09:39
Company Administration—
11 Aug 2025, 08:22
Financial ResultsMS
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 25 Sept 2026, 17:20 | AGM Date and Closing Date for Director Nominations | Meetings & Governance | — | 08006 | |
| 31 Aug 2026, 19:18 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 31 Aug 2026, 19:17 | Appendix 4E and Annual Report to shareholders | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 23 July 2026, 18:14 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 24 Apr 2026, 12:13 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 24 Apr 2026, 08:11 | Invex to Expand Preclinical Research Program | Company Update | — | 11001 | |
| 23 Mar 2026, 12:27 | Resignation of Joint Company Secretary | Company Administration | — | 12007 | |
| 17 Feb 2026, 18:40 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 12 Feb 2026, 13:34 | Appendix 4D and Half Year Report | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 22 Jan 2026, 16:16 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19002, 19007 | |
| 16 Jan 2026, 12:38 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 20 Nov 2025, 20:23 | Deferral of Annual General Meeting | Meetings & Governance | — | 08005 | |
| 10 Nov 2025, 13:02 | Initial Director's Interest Notice x 2 | Director Interests | — | 02008 | |
| 10 Nov 2025, 09:38 | Reinstatement to Quotation | Reinstatement | MS | 09002 | |
| 10 Nov 2025, 09:37 | Board and Officer Appointments and Company Address Change | Company Administration | MS | 12001, 12003, 12007 | |
| 7 Nov 2025, 15:44 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 7 Nov 2025, 15:22 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 7 Nov 2025, 15:22 | Resignation of Directors, Co Sec and Cancellation of Meeting | Meetings & Governance | — | 08006, 12001, 12007, 12008 | |
| 7 Nov 2025, 14:41 | Suspension from Official Quotation | Trading Halt / Suspension | MS | 09001 | |
| 7 Nov 2025, 14:20 | Pause in Trading | Trading Halt / Suspension | MS | 09005 | |
| 3 Nov 2025, 14:11 | Exenatide shows additional positive benefits in brain model | Company Update | — | 08006, 11001 | |
| 24 Oct 2025, 15:07 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004, 16002 | |
| 17 Oct 2025, 16:02 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 8 Oct 2025, 15:34 | Notice of General Meeting/Proxy Form | Meetings & Governance | — | 08004, 08007, 16002 | |
| 3 Oct 2025, 09:16 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 30 Sept 2025, 09:55 | Reinstatement to Quotation | Reinstatement | MS | 09002 | |
| 30 Sept 2025, 09:55 | Response to ASX Price and Volume Query | ASX Query | MS | 17003 | |
| 30 Sept 2025, 09:55 | Corporate Update | Company Update | MS | 11001 | |
| 29 Sept 2025, 12:09 | Director Nominations AGM | Meetings & Governance | — | 08006, 12008 | |
| 29 Sept 2025, 09:27 | Request for extension to voluntary suspension | Other | — | 11003 | |
| 25 Sept 2025, 09:40 | Suspension from Quotation | Trading Halt / Suspension | MS | 09001 | |
| 23 Sept 2025, 11:35 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 23 Sept 2025, 10:38 | Pause in Trading | Trading Halt / Suspension | MS | 09005 | |
| 18 Sept 2025, 10:42 | Notices received under sections 203D(2) and 249D of Corp Act | Company Administration | — | 12008 | |
| 11 Aug 2025, 09:39 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 11 Aug 2025, 08:22 | Appendix 4E and Annual Report to shareholders | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 |
1–36 of 36
1 / 1